Активы Изменить Дата
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
Amgen USD 96.05B 409M 2026-09
Baxter International USD 19.41B 377M 2026-09
Cara Therapeutics USD 23.53M 2.28M 2026-09
Cytokinetics USD 1.82B 99.77M 2026-09
DBV Technologies USD 215.4M 7.8M 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
MannKind USD 722.62M 9.69M 2026-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Pfizer USD 204.54B 3.41B 2026-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
United Therapeutics USD 7.03B 186M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12